# MapLight Therapeutics, Inc.: filings

MPLT · Nasdaq · CIK 1770069 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mplt.md) · [Financials](/companies/mplt/financials.md) · [Filings](/companies/mplt/filings.md) · [Insiders](/companies/mplt/insiders.md)

## Reports and events: 25 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 82, 144 45, 3 17, 8-K 11, D 6, 144/A 5, DRS/A 4, 10-Q 3, DRSLTR 3, SCHEDULE 13D/A 3, SCHEDULE 13G 3, UPLOAD 3, 424B3 2, D/A 2, FWP 2, S-1 2, S-1/A 2, S-8 2, SCHEDULE 13D 2, 10-K 1, 3/A 1, 8-A12B 1, ARS 1, CERT 1, DEF 14A 1, DEFA14A 1, DRS 1, EFFECT 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-18 | 20:15 ET | [S-1/A](/filings/0001193125-26-395559.md) | Registration statement, amended | 0001193125-26-395559 |
| 2026-09-09 | 21:28 ET | [S-1](/filings/0001193125-26-386648.md) | Registration statement | 0001193125-26-386648 |
| 2026-08-18 | 22:51 ET | [SCHEDULE 13D/A](/filings/0001104659-26-098444.md) | Ownership report, active investor, amended | 0001104659-26-098444 |
| 2026-08-13 | 21:01 ET | [10-Q](/filings/0001193125-26-349554.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349554 |
| 2026-08-13 | 20:51 ET | [8-K](/filings/0001193125-26-349490.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-349490 |
| 2026-08-03 | 01:00 ET | [SCHEDULE 13D/A](/filings/0001104659-26-089960.md) | Ownership report, active investor, amended | 0001104659-26-089960 |
| 2026-07-31 | 13:25 ET | [SCHEDULE 13D/A](/filings/0001388325-26-000034.md) | Ownership report, active investor, amended | 0001388325-26-000034 |
| 2026-07-27 | 11:07 ET | [8-K](/filings/0001193125-26-316820.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-316820 |
| 2026-06-24 | 11:12 ET | [8-K](/filings/0001193125-26-280243.md) | 5.07 Shareholder vote results | 0001193125-26-280243 |
| 2026-06-22 | 11:08 ET | [8-K](/filings/0001193125-26-276691.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-276691 |
| 2026-06-18 | 21:00 ET | [8-K](/filings/0001193125-26-276065.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-276065 |
| 2026-05-14 | 20:25 ET | [10-Q](/filings/0001193125-26-224129.md) | Quarterly report, period 2026-03-31 | 0001193125-26-224129 |
| 2026-05-14 | 20:15 ET | [8-K](/filings/0001193125-26-224067.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-224067 |
| 2026-04-29 | 20:11 ET | [8-K](/filings/0001193125-26-191566.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-191566 |
| 2026-04-29 | 20:02 ET | [DEF 14A](/filings/0001193125-26-191449.md) | Proxy statement, period 2026-06-23 | 0001193125-26-191449 |
| 2026-03-26 | 11:20 ET | [10-K](/filings/0001193125-26-125072.md) | Annual report, period 2025-12-31 | 0001193125-26-125072 |
| 2026-03-26 | 11:10 ET | [8-K](/filings/0001193125-26-125062.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-125062 |
| 2026-01-09 | 12:06 ET | [8-K](/filings/0001193125-26-008267.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-008267 |
| 2025-12-04 | 12:07 ET | [10-Q](/filings/0001193125-25-307453.md) | Quarterly report, period 2025-09-30 | 0001193125-25-307453 |
| 2025-12-04 | 12:03 ET | [8-K](/filings/0001193125-25-307450.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-307450 |
| 2025-11-20 | 00:37 ET | [SCHEDULE 13D](/filings/0001104659-25-114697.md) | Ownership report, active investor | 0001104659-25-114697 |
| 2025-11-04 | 21:21 ET | [SCHEDULE 13D](/filings/0001388325-25-000021.md) | Ownership report, active investor | 0001388325-25-000021 |
| 2025-10-29 | 13:12 ET | [8-K](/filings/0001193125-25-255041.md) | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-255041 |
| 2025-10-06 | 20:02 ET | [S-1/A](/filings/0001193125-25-231829.md) | Registration statement, amended | 0001193125-25-231829 |
| 2025-09-19 | 20:11 ET | [S-1](/filings/0001193125-25-209084.md) | Registration statement | 0001193125-25-209084 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.